Anti-IL-1α monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-IL-1α monoclonal antibody, covering 2025-05-30 to 2025-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine [Phase 1, Phase 2]